Literature DB >> 33064630

Evidence and speculations: vaccines and therapeutic options for COVID-19 pandemic.

Rabeea Siddique1,2, Qian Bai1,2, Muhammad Adnan Shereen3, Ghulam Nabi4, Guang Han5, Farooq Rashid6, Saeed Ahmed1,2, Aigerim Benzhanova1, Mengzhou Xue1,2, Suliman Khan1,2.   

Abstract

A novel coronavirus (2019-nCov) emerged in China, at the end of December 2019 which posed an International Public Health Emergency, and later declared as a global pandemic by the World Health Organization (WHO). The International Committee on Taxonomy of Viruses (ICTV) named it SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), while the disease was named COVID-19 (Coronavirus Disease- 2019). Many questions related to the exact mode of transmission, animal origins, and antiviral therapeutics are not clear yet. Nevertheless, it is required to urgently launch a new protocol to evaluate the side effects of unapproved vaccines and antiviral therapeutics to accelerate the clinical application of new drugs. In this review, we highlight the most salient characteristics and recent findings of COVID-19 disease, molecular virology, interspecies mechanisms, and health consequences related to this disease.

Entities:  

Keywords:  SARS-CoV-2; covid-19; genome; human health; therapeutic options; vaccine development

Mesh:

Substances:

Year:  2020        PMID: 33064630      PMCID: PMC8018497          DOI: 10.1080/21645515.2020.1824497

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  63 in total

1.  The COVID-19 vaccine development landscape.

Authors:  Tung Thanh Le; Zacharias Andreadakis; Arun Kumar; Raúl Gómez Román; Stig Tollefsen; Melanie Saville; Stephen Mayhew
Journal:  Nat Rev Drug Discov       Date:  2020-05       Impact factor: 84.694

2.  Developing Covid-19 Vaccines at Pandemic Speed.

Authors:  Nicole Lurie; Melanie Saville; Richard Hatchett; Jane Halton
Journal:  N Engl J Med       Date:  2020-03-30       Impact factor: 91.245

3.  Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates.

Authors:  Jie Li; Laura Ulitzky; Erica Silberstein; Deborah R Taylor; Raphael Viscidi
Journal:  Viral Immunol       Date:  2013-04       Impact factor: 2.257

4.  Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.

Authors:  Maria L Agostini; Erica L Andres; Amy C Sims; Rachel L Graham; Timothy P Sheahan; Xiaotao Lu; Everett Clinton Smith; James Brett Case; Joy Y Feng; Robert Jordan; Adrian S Ray; Tomas Cihlar; Dustin Siegel; Richard L Mackman; Michael O Clarke; Ralph S Baric; Mark R Denison
Journal:  mBio       Date:  2018-03-06       Impact factor: 7.867

5.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Authors:  Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan
Journal:  Science       Date:  2020-02-19       Impact factor: 47.728

Review 6.  Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development.

Authors:  Ruklanthi de Alwis; Shiwei Chen; Esther S Gan; Eng Eong Ooi
Journal:  EBioMedicine       Date:  2020-04-16       Impact factor: 8.143

7.  A new coronavirus associated with human respiratory disease in China.

Authors:  Fan Wu; Su Zhao; Bin Yu; Yan-Mei Chen; Wen Wang; Zhi-Gang Song; Yi Hu; Zhao-Wu Tao; Jun-Hua Tian; Yuan-Yuan Pei; Ming-Li Yuan; Yu-Ling Zhang; Fa-Hui Dai; Yi Liu; Qi-Min Wang; Jiao-Jiao Zheng; Lin Xu; Edward C Holmes; Yong-Zhen Zhang
Journal:  Nature       Date:  2020-02-03       Impact factor: 49.962

8.  Characteristics of COVID-19 infection in Beijing.

Authors:  Sijia Tian; Nan Hu; Jing Lou; Kun Chen; Xuqin Kang; Zhenjun Xiang; Hui Chen; Dali Wang; Ning Liu; Dong Liu; Gang Chen; Yongliang Zhang; Dou Li; Jianren Li; Huixin Lian; Shengmei Niu; Luxi Zhang; Jinjun Zhang
Journal:  J Infect       Date:  2020-02-27       Impact factor: 6.072

Review 9.  Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.

Authors:  Yixuan Wang; Yuyi Wang; Yan Chen; Qingsong Qin
Journal:  J Med Virol       Date:  2020-03-29       Impact factor: 20.693

Review 10.  Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.

Authors:  Hui Luo; Qiao-Ling Tang; Ya-Xi Shang; Shi-Bing Liang; Ming Yang; Nicola Robinson; Jian-Ping Liu
Journal:  Chin J Integr Med       Date:  2020-02-17       Impact factor: 1.978

View more
  3 in total

Review 1.  Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review.

Authors:  Adekunle Sanyaolu; Chuku Okorie; Aleksandra Marinkovic; Stephanie Prakash; Martina Williams; Nafees Haider; Jasmine Mangat; Zaheeda Hosein; Vyshnavy Balendra; Abu Fahad Abbasi; Priyank Desai; Isha Jain; Stephen Utulor; Amos Abioye
Journal:  Ther Adv Vaccines Immunother       Date:  2022-05-30

Review 2.  Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease.

Authors:  Tafere Mulaw Belete
Journal:  Infect Drug Resist       Date:  2021-01-19       Impact factor: 4.003

Review 3.  A Look at COVID-19 Global Health Situation, 1-Year Post Declaration of the Pandemic.

Authors:  Adekunle Sanyaolu; Aleksandra Marinkovic; Stephanie Prakash; Abu Fahad Abbasi; Risha Patidar; Martina Williams; Anne Zhao; Gideon Dzando; Chuku Okorie; Ricardo Izurieta
Journal:  Microbiol Insights       Date:  2022-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.